WEG
CVS icon

World Equity Group’s CVS Health CVS Stock Holding History

World Equity Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,932
Closed -$498K – 399
2026
Q1 		$498K Buy
6,932
+1,479
+27% +$114K 0.13% 192
2025
Q4 		$433K Buy
+5,453
New +$430K 0.12% 188
2024
Q3 		– Sell
-12,524
Closed -$740K – 275
2024
Q2 		$740K Sell
12,524
-12,474
-50% -$780K 0.22% 119
2024
Q1 		$1.99M Sell
24,998
-198
-0.8% -$15.1K 0.41% 63
2023
Q4 		$1.99M Buy
25,196
+194
+0.8% +$13.8K 0.4% 57
2023
Q3 		$1.75M Buy
25,002
+12,837
+106% +$910K 0.36% 62
2023
Q2 		$841K Sell
12,165
-864,172
-99% -$61.5M 0.25% 107
2023
Q1 		$876K Buy
876,337
+868,592
+11,215% +$72.8M 0.13% 180
2022
Q4 		$722K Buy
7,745
+311
+4% +$30K 0.17% 139
2022
Q3 		$709K Sell
7,434
-110
-1% -$10.9K 0.18% 130
2022
Q2 		$699K Buy
7,544
+637
+9% +$62.2K 0.18% 144
2022
Q1 		$699K Buy
+6,907
New +$726K 0.15% 167

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

World Equity Group's CVS Position: Q2 2026 in Review

World Equity Group sold out of CVS Health (CVS) in Q2 2026, closing a stake of 6,932 shares — an estimated $498K sold.

World Equity Group first reported a position in CVS in Q1 2022 and held it in 12 quarters. The position peaked at $1.99M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • World Equity Group reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • World Equity Group sold 6,932 CVS Health shares in Q2 2026, an estimated $498K.
  • World Equity Group first reported a position in CVS Health in Q1 2022 and held it in 12 quarters.
  • World Equity Group's CVS Health position peaked at $1.99M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on World Equity Group's 13F filing for Q2 2026, filed 9 Jul 2026.